MRKR financials
Marker Therapeutics (MRKR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
MRKR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $3.55M | – | -$12.89M | -$12.16M | -0.79 |
| 2024 | $6.59M | – | -$11.12M | -$10.73M | -1.19 |
| 2023 | $3.31M | – | -$14.58M | -$8.24M | -0.94 |
| 2022 | $3.51M | – | -$19.79M | -$29.93M | -3.58 |
| 2021 | $1.24M | – | -$39.48M | -$41.88M | -5.47 |
| 2020 | $466.79K | – | -$28.89M | -$28.71M | -6.10 |
- MRKR revenue was $3.55M in fiscal 2025, net income -$12.16M.
Updated 2026-11-20 21:45 UTC